Author

Armelle Caty

Observed names: A Caty, A. CATY, A. Caty

Observed institutions: Université de Lyon, Herlev Hospital, Institut Gustave Roussy, Rigshospitalet, Centre Hospitalier Universitaire de Bordeaux, Centre Hospitalier Universitaire de Lille, Institute Mutualiste Montsouris, Centre Georges François Leclerc, Hôpital Européen Georges-Pompidou, Hôpital Jeanne de Flandre, Centre Léon Bérard, Hôpital de Jolimont, Centre Eugène Marquis, Centre Hospitalier Universitaire de Caen Normandie, Centre Hospitalier Universitaire de Limoges, Centre François Baclesse, Hôpital Edouard Herriot, Vall d'Hebron Hospital Universitari, Institut Claudius Regaud, Hôpitaux Universitaires Henri-Mondor, Hospital Del Mar, Centre Oscar Lambret, Hôpital Lapeyronie, Institut Bergonié, Hôpitaux Universitaires de Strasbourg, Institut Paoli-Calmettes, Centre Antoine Lacassagne, Hôpital Claude Huriez, Hôpital Foch

OpenAlex ID: A5002114271

Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract

2009 · Joaquim Bellmunt, Christine Théodore, et al. · Journal of Clinical Oncology · 770

PDF

Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)

2007 · S. Culine, P. Kerbrat, et al. · Annals of Oncology · 209

Medroxyprogesterone, interferon alfa‐2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis

2007 · Sylvie Negrier, David Perol, et al. · Cancer · 184

PDF

Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

2012 · Laurence Albiges, Stéphane Oudard, et al. · Journal of Clinical Oncology · 163

Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic: A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial

2008 · Nicholas D. James, Armelle Caty, et al. · European Urology · 160

Treatment of Patients With Metastatic Renal Carcinoma With a Combination of Subcutaneous Interleukin-2 and Interferon Alfa With or Without Fluorouracil

2000 · Sylvie Négrier, Armelle Caty, et al. · Journal of Clinical Oncology · 135

Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration‐resistant prostate cancer and bone metastases who were pain‐free or mildly symptomatic for pain: a double‐blind, placebo‐controlled, randomized Phase II trial

2010 · Nicholas D. James, Armelle Caty, et al. · British Journal of Urology · 111

Randomized Trial Comparing Bleomycin/Etoposide/Cisplatin With Alternating Cisplatin/Cyclophosphamide/Doxorubicin and Vinblastine/Bleomycin Regimens of Chemotherapy for Patients With Intermediate- and Poor-Risk Metastatic Nonseminomatous Germ Cell Tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP

2008 · Stéphane Culine, Andrew Kramar, et al. · Journal of Clinical Oncology · 102

Cytokines in Metastatic Renal Cell Carcinoma: Is It Useful to Switch to Interleukin-2 or Interferon After Failure of a First Treatment?

1999 · Bernard Escudier, Christine Chevreau, et al. · Journal of Clinical Oncology · 89

Do cytokines improve survival in patients with metastatic renal cell carcinoma (MRCC) of intermediate prognosis? Results of the prospective randomized PERCY Quattro trial

2005 · S. Negrier, D. Perol, et al. · Journal of Clinical Oncology · 86

Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie.

1998 · A Ravaud, B Audhuy, et al. · Journal of Clinical Oncology · 80

Extraperitoneal Laparoscopic Para-aortic Lymph Node Dissection for Early Stage Nonseminomatous Germ Cell Tumors of the Testis With Introduction of a Nerve Sparing Technique: Description and Results

2001 · E. LeBLANC, A. CATY, et al. · The Journal of Urology · 74

Nonseminomatous germ cell tumors: Assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis

2009 · Benjamin Besse, Dominique Grunenwald, et al. · Journal of Thoracic and Cardiovascular Surgery · 67

PDF

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder

1991 · A. Boutan-Laroze, M. Mahjoubi, et al. · European Journal of Cancer and Clinical Oncology · 67

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial

2005 · J.-P. Lotz, B. Bui, et al. · Annals of Oncology · 57

Quality of Life in Long-Term Survivors of Nonseminomatous Germ Cell Testicular Tumors

1993 · J. Douchez, J.P. Droz, et al. · The Journal of Urology · 53

A Risk-adapted Study of Cisplatin and Etoposide, with or Without Ifosfamide, in Patients with Metastatic Seminoma: Results of the GETUG S99 Multicenter Prospective Study

2013 · Karim Fizazi, Rémi Delva, et al. · European Urology · 51

Phase II study of vinorelbine in patients with androgen-independent prostate cancer

2001 · S. Oudard, A. Caty, et al. · Annals of Oncology · 46

PDF

Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib

2014 · Benoit Beuselinck, Diether Lambrechts, et al. · Acta Oncologica · 34

PDF

A randomized double-blind study evaluating anandron® associated with orchiectomy in stage D prostate cancer

1990 · M. Namer, J. Toubol, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 34

A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study

2014 · F. Selle, S. Wittnebel, et al. · Annals of Oncology · 32

PDF

Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy

2019 · Stéphane Oudard, Igor Latorzeff, et al. · JAMA Oncology · 30

PDF

Randomised phase III trial of vinflunine (V) plus best supportive care (B) vs B alone as 2nd line therapy after a platinum-containing regimen in advanced transitional cell carcinoma of the urothelium (TCCU)

2008 · J. Bellmunt Molins, H. von der Maase, et al. · Journal of Clinical Oncology · 28

Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study

2017 · Emeline Colomba, Gwénaël Le Teuff, et al. · European Journal of Cancer · 23

Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors.

1991 · C Fournier, B Hecquet, et al. · PubMed · 20

Works count: 84

Citation count: 2,877

H-index: 23

I10-index: 30